Pregled bibliografske jedinice broj: 1253843
Guía ESPEN: Nutrición clínica en la enfermedad inflamatoria intestinal
Guía ESPEN: Nutrición clínica en la enfermedad inflamatoria intestinal // Nutrición Hospitalaria, 39 (2022), 3; 678-703 doi:10.20960/nh.03857 (recenziran, pregledni rad, znanstveni)
CROSBI ID: 1253843 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Guía ESPEN: Nutrición clínica en la enfermedad
inflamatoria intestinal
(ESPEN guideline: Clinical nutrition in inflammatory
bowel disease)
Autori
Bischoff, Stephan C. ; Escher, Johanna ; Hébuterne, Xavier ; Kłęk, Stanisław ; Krznaric, Zeljko ; Schneider, Stéphane ; Shamir, Raanan ; Stardelova, Kalina ; Wierdsma, Nicolette ; Wiskin, Anthony E ; Forbes, Alastair ; Montoro, Miguel ; Burgos Peláez, Rosa
Izvornik
Nutrición Hospitalaria (1699-5198) 39
(2022), 3;
678-703
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
Enfermedad de Crohn ; Colitis ulcerosa ; Nutrición enteral ; Nutrición parenteral ; Enfermedad inflamatoria intestinal ; Terapia nutricional
(Crohn's disease ; Ulcerative colitis ; Enteral nutrition ; Parenteral nutrition ; Inflammatory bowel disease ; Nutritional therapy)
Sažetak
Introduction: the ESPEN guideline offers a multidisciplinary focus on clinical nutrition in inflammatory bowel disease (IBD). Methodology: the guideline is based on a extensive systematic review of the literature, but relies on expert opinion when objective data are lacking or inconclusive. The conclusions and 64 recommendations have been subject to full peer review and a Delphi process, in which uniformly positive responses (agree or strongly agree) were required. Results: IBD is increasingly common and potential dietary factors in its etiology are briefly reviewed. Malnutrition is highly prevalent in IBD - especially in Crohn's disease. Increased energy and protein requirements are observed in some patients. The management of malnutrition in IBD is considered within the general context of support for malnourished patients. Treatment of iron deficiency (parenterally, if necessary) is strongly recommended. Routine provision of a special diet in IBD is not, however, supported. Parenteral nutrition is indicated only when enteral nutrition has failed or is impossible. The recommended perioperative management of patients with IBD undergoing surgery accords with general ESPEN guidance for patients having abdominal surgery. Probiotics may be helpful in UC but not in Crohn's disease. Primary therapy using nutrition to treat IBD is not supported in ulcerative colitis but is moderately well supported in Crohn's disease, especially in children, where the adverse consequences of steroid therapy are proportionally greater. However, exclusion diets are generally not recommended and there is little evidence to support any particular formula feed when nutritional regimens are constructed. Conclusions: available objective data to guide nutritional support and primary nutritional therapy in IBD are presented as 64 recommendations, of which 9 are very strong recommendations (grade A), 22 are strong recommendations (grade B), and 12 are based only on sparse evidence (grade 0) ; 21 recommendations are good practice points (GPP).
Izvorni jezik
Ita
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Željko Krznarić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE